ClinicalTrials.Veeva

Menu

The Behavioral Effects of Opioids and Alcohol

S

Sharon Walsh

Status and phase

Completed
Phase 1

Conditions

Opioid Use
Alcohol Drinking

Treatments

Drug: Alcohol
Drug: Opioid Agonist

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT04300751
55176
R01DA016718 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

This study will examine the effects of doses of alcohol/placebo and doses of opioid/placebo, alone and in combination. The primary outcomes are related to pharmacodynamic measures (subjective ratings of drug liking and other abuse-related effects; physiological outcomes) to determine the interaction effects of these compounds.

Enrollment

11 patients

Sex

All

Ages

21 to 55 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Healthy adults ages 21-55
  • Current non-medical use of opioids
  • Previous alcohol use

Exclusion criteria

  • Physical dependence on opioids, alcohol, or benzodiazepines/sedative/hypnotics
  • Seeking treatment for drug use
  • Significant medical problems

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

11 participants in 3 patient groups

Alcohol
Experimental group
Description:
Participants will receive experimental doses of active or placebo alcohol, p.o. Alcohol/placebo will be administered once per session.
Treatment:
Drug: Alcohol
Opioid Agonist
Experimental group
Description:
Participants will receive non-therapeutic, experimental doses of an active opioid agonist or placebo. Active opioid agonist/placebo will be administered once per session and will be administered orally
Treatment:
Drug: Opioid Agonist
Opioid Agonist/Alcohol Combination
Experimental group
Description:
Participants will receive non-therapeutic, experimental doses of active opioid/placebo in combination with experimental doses of active alcohol placebo. Opioid/placebo and alcohol/placebo doses will be administered once during each session. It is possible to receive both active drugs on the same day. Both opioid and alcohol doses will be administered orally.
Treatment:
Drug: Opioid Agonist
Drug: Alcohol

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

Paul Nuzzo, MA; Stevie Britch, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems